Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry

Eur Respir J. 2021 Aug 26;58(2):2101483. doi: 10.1183/13993003.01483-2021. Print 2021 Aug.

Karen M Olsson^{1

2}, Marius M Hoeper^{3

2}, Christine Pausch⁴, Ekkehard Grünig⁵, Doerte Huscher⁶, David Pittrow^{4

7}, Stephan Rosenkranz⁸, Henning Gall^{2

9}

¹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
² German Centre of Lung Research (DZL), Germany.
³ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.
⁴ GWT-TUD GmbH, Epidemiological Centre, Dresden, Germany.
⁵ Centre for Pulmonary Hypertension, Thoraxclinic Heidelberg GmbH at Heidelberg University Hospital, Heidelberg, Germany.
⁶ Institute of Biometry and Clinical Epidemiology, Charité Universitätsmedizin, Berlin, Germany.
⁷ Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
⁸ Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), and the Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
⁹ Dept of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.

No abstract available

Publication types